{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:12:28Z","timestamp":1780582348557,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005066","name":"Key Medical Subjects of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.yexcr.2019.111588","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T12:21:44Z","timestamp":1567081304000},"page":"111588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Tumor infiltrating M2 macrophages could predict biochemical recurrence of localized prostate cancer after radical prostatectomy"],"prefix":"10.1016","volume":"384","author":[{"given":"Qijie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiadong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjian","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninghong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2019.111588_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12950-016-0143-2","article-title":"Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review","volume":"13","author":"Sciarra","year":"2016","journal-title":"J. Inflamm."},{"issue":"3","key":"10.1016\/j.yexcr.2019.111588_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000481438","article-title":"Management of biochemical recurrence after primary curative treatment for prostate cancer: a review","volume":"100","author":"Artibani","year":"2018","journal-title":"Urol. Int."},{"issue":"6","key":"10.1016\/j.yexcr.2019.111588_bib3","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0022-5347(05)67511-8","article-title":"Prostate specific antigen only progression of prostate cancer","volume":"163","author":"Moul","year":"2000","journal-title":"J. Urol."},{"issue":"4","key":"10.1016\/j.yexcr.2019.111588_bib4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur. Urol."},{"issue":"11","key":"10.1016\/j.yexcr.2019.111588_bib5","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.yexcr.2019.111588_bib6","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/cas.13287","article-title":"High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer","volume":"108","author":"Miyasato","year":"2017","journal-title":"Canc. Sci."},{"issue":"1","key":"10.1016\/j.yexcr.2019.111588_bib7","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/s41598-017-01661-z","article-title":"CD163(+)CD204(+) tumor-associated macrophages contribute to T cell regulation via interleukin-10 and PD-L1 production in oral squamous cell carcinoma","volume":"7","author":"Kubota","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.yexcr.2019.111588_bib8","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1349-7006.2011.01945.x","article-title":"Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma","volume":"102","author":"Komohara","year":"2011","journal-title":"Canc. Sci."},{"issue":"7446","key":"10.1016\/j.yexcr.2019.111588_bib9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.yexcr.2019.111588_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ccr.2013.02.013","article-title":"Macrophage regulation of tumor responses to anticancer therapies","volume":"23","author":"De Palma","year":"2013","journal-title":"Canc. Cell"},{"issue":"18","key":"10.1016\/j.yexcr.2019.111588_bib11","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1158\/0008-5472.CAN-13-3723","article-title":"CSF1\/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models","volume":"74","author":"Zhu","year":"2014","journal-title":"Canc. Res."},{"key":"10.1016\/j.yexcr.2019.111588_bib12","first-page":"389","volume":"vol.9","author":"Arlauckas","year":"2017"},{"key":"10.1016\/j.yexcr.2019.111588_bib13","first-page":"363","volume":"vol.79","author":"Erlandsson","year":"2019"},{"issue":"2","key":"10.1016\/j.yexcr.2019.111588_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0090-4295(02)02268-9","article-title":"Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen","volume":"61","author":"Freedland","year":"2003","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.yexcr.2019.111588_bib15","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/01.ju.0000134888.22332.bb","article-title":"Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results","volume":"172","author":"Roehl","year":"2004","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.yexcr.2019.111588_bib16","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/bju.14556","article-title":"Late biochemical recurrence after radical prostatectomy is associated with a slower rate of progression","volume":"123","author":"Chow","year":"2018","journal-title":"BJU Int."},{"issue":"4","key":"10.1016\/j.yexcr.2019.111588_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.amjms.2017.01.006","article-title":"MiR-1, a potential predictive biomarker for recurrence in prostate cancer after radical prostatectomy","volume":"353","author":"Wei","year":"2017","journal-title":"Am. J. Med. Sci."},{"issue":"6","key":"10.1016\/j.yexcr.2019.111588_bib18","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.3892\/mmr.2016.5859","article-title":"miR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma","volume":"14","author":"Xu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.yexcr.2019.111588_bib19","article-title":"Identification of seven long noncoding RNAs signature for prediction of biochemical recurrence in prostate cancer","author":"Shao","year":"2019","journal-title":"Asian J. Androl."},{"issue":"2","key":"10.1016\/j.yexcr.2019.111588_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4111\/icu.2019.60.2.84","article-title":"CRTC2 as a novel prognostic biomarker for worse pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with prostate cancer","volume":"60","author":"Lee","year":"2019","journal-title":"Investig. Clin. Urol."},{"issue":"3","key":"10.1016\/j.yexcr.2019.111588_bib21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11255-019-02096-3","article-title":"SAMD5 mRNA was overexpressed in prostate cancer and can predict biochemical recurrence after radical prostatectomy","volume":"51","author":"Li","year":"2019","journal-title":"Int. Urol. Nephrol."},{"issue":"1","key":"10.1016\/j.yexcr.2019.111588_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013820","article-title":"PITX2 methylation: a novel and effective biomarker for monitoring biochemical recurrence risk of prostate cancer","volume":"98","author":"Jiang","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.yexcr.2019.111588_bib23","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.2147\/CMAR.S175869","article-title":"Preoperative PROSTATE scoring system: a potential predictive tool for the risk of biochemical recurrence after radical prostatectomy","volume":"10","author":"Zhang","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.yexcr.2019.111588_bib24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s41824-018-0034-2","article-title":"Pre-treatment (18)F-choline PET\/CT is prognostic for biochemical recurrence, development of bone metastasis, and cancer specific mortality following radical local therapy of high-risk prostate cancer","volume":"2","author":"Kjolhede","year":"2018","journal-title":"Eur. J. Hybrid Imag."},{"issue":"3","key":"10.1016\/j.yexcr.2019.111588_bib25","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/cam4.1984","article-title":"The preoperative neutrophil-to-lymphocyte ratio is not a marker of prostate cancer characteristics but is an independent predictor of biochemical recurrence in patients receiving radical prostatectomy","volume":"8","author":"Cao","year":"2019","journal-title":"Canc. Med."},{"issue":"5","key":"10.1016\/j.yexcr.2019.111588_bib26","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1189\/jlb.0609385","article-title":"Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation","volume":"86","author":"Solinas","year":"2009","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.yexcr.2019.111588_bib27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"issue":"11","key":"10.1016\/j.yexcr.2019.111588_bib28","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.acra.2018.02.017","article-title":"Incremental prognostic value of apparent diffusion coefficient histogram analysis in head and neck squamous cell carcinoma","volume":"25","author":"Li","year":"2018","journal-title":"Acad. Radiol."},{"issue":"43","key":"10.1016\/j.yexcr.2019.111588_bib29","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2019.111588_bib30","article-title":"Radiomics on multi-modalities MR sequences can subtype patients with non-metastatic nasopharyngeal carcinoma (NPC) into distinct survival subgroups","author":"Zhuo","year":"2019","journal-title":"Eur. Radiol."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482719304458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482719304458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:27:34Z","timestamp":1757996854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482719304458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0014482719304458"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2019.111588","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor infiltrating M2 macrophages could predict biochemical recurrence of localized prostate cancer after radical prostatectomy","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2019.111588","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111588"}}